TD Cowen raised the firm’s price target on Exact Sciences (EXAS) to $90 from $74 and keeps a Buy rating on the shares. The firm said Q3 results were solid with the strongest quarterly Cologuard volume growth (+23% Y/Y) and most sales upside (5% greater than cons.) in nearly 3 yrs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences price target raised to $85 from $75 at BTIG
- Exact Sciences price target raised to $80 from $67 at Stifel
- Exact Sciences: Strong Growth Potential and Strategic Initiatives Justify Buy Rating
- Exact Sciences price target raised to $77 from $65 at Barclays
- Exact Sciences: Strong Q3 Performance and Promising Outlook Drive Buy Rating and Increased Price Target